ANASYOR - USA CORPORATION – Trademark Portfolio

Entity Type: 03

ANASYOR - USA CORPORATION holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OSCILLO and OSCILLOCOCCINUM. The owner is based in HOUSTON, TX.

6100 CORPORATE DRIVE, SUITE 470

HOUSTON, TX 77036

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ANASYOR - USA CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does ANASYOR - USA CORPORATION have?

ANASYOR - USA CORPORATION has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does ANASYOR - USA CORPORATION file in?

ANASYOR - USA CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ANASYOR - USA CORPORATION's most well-known trademarks?

ANASYOR - USA CORPORATION's registered trademark portfolio includes well-known marks such as OSCILLO and OSCILLOCOCCINUM. These are among 2 currently registered trademarks in the portfolio.

What is ANASYOR - USA CORPORATION's trademark registration success rate?

ANASYOR - USA CORPORATION has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.